Plain-English translation of NCT06948591 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study is tracking the real-world safety and effectiveness of BioBrace, a supportive tissue material used during ACL (anterior cruciate ligament) knee reconstruction surgery. Researchers want to understand how well the surgery works when BioBrace is added to the tissue graft, and whether people return to their normal activities and sports. You would share your recovery progress through check-ins over three years after surgery.
ACL tears are common knee injuries, and surgery is often needed to fix them. This medication aims to give the tissue graft extra support and strength to help patients heal better and return to activities faster. The study exists to see whether this treatment works well in real-world conditions, outside of controlled research settings.
You likely qualify if…
You likely don't qualify if…
You would attend clinic visits before surgery and then at 6 months, 1 year, 2 years, and 3 years after your ACL reconstruction with BioBrace. At each visit, you'll complete questionnaires about your knee pain, how well your knee functions, whether you've returned to sports or activities, and any side effects. The study will track your progress and safety over the full three-year period to understand how well this treatment works.
AI-generated summary from trial data · Aug 28, 2026 · Not medical advice
United States
Sponsor
CONMED Corporation
Enrollment target
~500 participants
Started
April 2025
Primary completion
June 2030
Age range
14 Years – 70 Years
Last updated on clinicaltrials.gov in April 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Kelley Grynewicz
CONMED Corporation
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.